TARRYTOWN, N.Y. – Tarrytown-based Regeneron Pharmaceuticals has been named the Biotechnology Company of the Year by Scrip Intelligence.
“We are honored to be recognized by Scrip, a leading industry publication,” Leonard Schleifer, president and CEO of Regeneron, said in a statement. “This has indeed been a transforming time for Regeneron, as we went from having one approved drug to three, advanced investigational drugs into Phase 3 trials, and created shareholder value that moved Regeneron into the top ranks of the biotechnology industry.”
Scrip Intelligence announced the award in late November. The award recognizes Regeneron's accomplishments in the past 12 months. A panel of 16 pharmaceutical executives, consultants and researchers selected award winners.
Click here to sign up for Daily Voice's free daily emails and news alerts.